6 days ago
EWTX
AnalystsSrikripa DevarakondaSrikripa Devarakonda's Stock Forecasts
AnalystsSrikripa Devarakonda
Sectors:
Industries:
Analyst Ranking
Top 27%
#1260 out of 4753 analysts
Average Return
+6.29%
Win Rate
41%20 out of 49
Risk vs Reward
Poor
Good
Srikripa Devarakonda's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +149.24% | $15.23 | $37.96 | 2024-04-02 - 2024-12-02 | Strong Buy |
Scholar Rock Holding CorpSRRK | +137.10% | $16.01 | $37.96 | 2024-03-24 - 2024-12-02 | Strong Buy |
Edgewise Therapeutics IncEWTX | +131.48% | $7.56 | $17.50 | 2023-06-27 - 2024-06-27 | Strong Buy |
Verastem IncVSTM | +121.69% | $2.49 | $5.52 | 2024-08-12 - 2024-12-02 | Strong Buy |
Verastem IncVSTM | +111.49% | $2.61 | $5.52 | 2024-07-07 - 2024-12-02 | Strong Buy |
Srikripa Devarakonda Analyst Color
Get additional color on Srikripa Devarakonda's coverage of popular stocks
8 days ago
SRRK
2 months ago
LLY
5 months ago
LLY
7 months ago
LLY
9 months ago
KYMR
Srikripa Devarakonda's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Edgewise Therapeutics IncEWTX | 6 | Strong Buy | $50.00 | +58.53% | Maintains | 6 days ago |
Scholar Rock Holding CorpSRRK | 4 | Strong Buy | $45.00 | +18.55% | Maintains | 8 days ago |
Regeneron Pharmaceuticals IncREGN | 4 | Strong Buy | $1,126.00 | +47.70% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 3 | Strong Buy | $53.00 | +11.02% | Reiterates | a month ago |
Eli Lilly & CoLLY | 3 | Strong Buy | $1,033.00 | +29.16% | Maintains | 2 months ago |
Abbvie IncABBV | 1 | Strong Buy | $215.00 | +18.28% | Maintains | 2 months ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $54.00 | +642.78% | Upgrades | 2 months ago |
Incyte CorpINCY | 8 | Hold | $74.00 | +1.04% | Downgrades | 2 months ago |
Protagonist Therapeutics IncPTGX | 1 | Strong Buy | $60.00 | +38.70% | Initiates Coverage On | 3 months ago |
Verastem IncVSTM | 7 | Strong Buy | $15.00 | +171.74% | Maintains | 4 months ago |
Biogen IncBIIB | 1 | Strong Buy | $302.00 | +83.89% | Reiterates | 4 months ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $36.00 | +67.52% | Initiates Coverage On | 4 months ago |
Keros Therapeutics IncKROS | 3 | Strong Buy | $100.00 | +76.27% | Maintains | 5 months ago |
Cytokinetics IncCYTK | 4 | Strong Buy | $70.00 | +38.26% | Maintains | 6 months ago |
Affimed NvAFMD | 2 | Strong Buy | $60.00 | N/A | Maintains | a year ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $38.00 | N/A | Downgrades | 2 years ago |
Constellation Pharmaceuticals IncCNST | 2 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.